Digestive System Diseases  >>  dronabinol oral  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dronabinol oral / Generic mfg.
NCT01253408: Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)

Completed
2
36
US
Dronabinol, Marinol, Placebo
Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Center for Research Resources (NCRR)
Irritable Bowel Syndrome
12/11
12/11
NCT01786109: Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome

Completed
2
75
US
Dronabinol, Marimol, Placebo
Michael Camilleri, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Center for Research Resources (NCRR)
Irritable Bowel Syndrome
12/11
12/11
Delta-pain, NCT01318369 / 2011-000647-24: Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

Completed
2
24
Europe
Namisol, Dronabinol, THC, Diazepam
Radboud University Medical Center
Cannabinoid, Tetrahydrocannabinol, Chronic Pancreatitis, Abdominal Pain
05/13
05/13
NCT01551511 / 2012-000730-19: Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

Completed
2
29
Europe
Tetrahydrocannabinol, Namisol, Dronabinol, Placebo
Radboud University Medical Center, European Union
Pancreatitis, Chronic, Abdominal Pain, Chronic Pain
06/14
06/14

Download Options